JPH04197193A - Production of nucleoside compound - Google Patents
Production of nucleoside compoundInfo
- Publication number
- JPH04197193A JPH04197193A JP32233190A JP32233190A JPH04197193A JP H04197193 A JPH04197193 A JP H04197193A JP 32233190 A JP32233190 A JP 32233190A JP 32233190 A JP32233190 A JP 32233190A JP H04197193 A JPH04197193 A JP H04197193A
- Authority
- JP
- Japan
- Prior art keywords
- base
- nucleoside
- phosphate
- reaction
- inosine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002777 nucleoside Substances 0.000 title claims abstract description 29
- -1 nucleoside compound Chemical class 0.000 title claims abstract description 18
- 238000004519 manufacturing process Methods 0.000 title claims description 25
- 238000006243 chemical reaction Methods 0.000 claims abstract description 52
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims abstract description 30
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims abstract description 16
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 claims abstract description 14
- VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 claims abstract description 13
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims abstract description 12
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 claims abstract description 12
- 150000003833 nucleoside derivatives Chemical class 0.000 claims abstract description 12
- 229940116269 uric acid Drugs 0.000 claims abstract description 12
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000007864 aqueous solution Substances 0.000 claims abstract description 4
- 229960003786 inosine Drugs 0.000 claims description 26
- 229930010555 Inosine Natural products 0.000 claims description 25
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 claims description 25
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims description 22
- 102100033220 Xanthine oxidase Human genes 0.000 claims description 21
- 108010093894 Xanthine oxidase Proteins 0.000 claims description 21
- VGONTNSXDCQUGY-UHFFFAOYSA-N desoxyinosine Natural products C1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 VGONTNSXDCQUGY-UHFFFAOYSA-N 0.000 claims description 12
- 101710101148 Probable 6-oxopurine nucleoside phosphorylase Proteins 0.000 claims description 10
- 102000030764 Purine-nucleoside phosphorylase Human genes 0.000 claims description 10
- 102000001853 Pyrimidine Phosphorylases Human genes 0.000 claims description 10
- 108010054917 Pyrimidine Phosphorylases Proteins 0.000 claims description 10
- 150000003013 phosphoric acid derivatives Chemical class 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 abstract description 9
- 108090000790 Enzymes Proteins 0.000 abstract description 9
- 150000003839 salts Chemical class 0.000 abstract description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 2
- 102000009097 Phosphorylases Human genes 0.000 abstract 1
- 108010073135 Phosphorylases Proteins 0.000 abstract 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 1
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 32
- 239000000243 solution Substances 0.000 description 23
- 229940113082 thymine Drugs 0.000 description 16
- YXJDFQJKERBOBM-TXICZTDVSA-N alpha-D-ribose 1-phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H]1O YXJDFQJKERBOBM-TXICZTDVSA-N 0.000 description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 12
- DWRXFEITVBNRMK-JXOAFFINSA-N ribothymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 DWRXFEITVBNRMK-JXOAFFINSA-N 0.000 description 12
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 12
- KBDKAJNTYKVSEK-PYHARJCCSA-N 2-deoxy-D-ribofuranose 1-phosphate Chemical compound OC[C@H]1OC(OP(O)(O)=O)C[C@@H]1O KBDKAJNTYKVSEK-PYHARJCCSA-N 0.000 description 9
- 229910019142 PO4 Inorganic materials 0.000 description 9
- 239000010452 phosphate Substances 0.000 description 9
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 229910000160 potassium phosphate Inorganic materials 0.000 description 6
- 235000011009 potassium phosphates Nutrition 0.000 description 6
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 229940075420 xanthine Drugs 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- XZQJHVLZFUSEGR-OYUVGMAPSA-N 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione phosphoric acid Chemical compound OP(O)(O)=O.O=C1NC(=O)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 XZQJHVLZFUSEGR-OYUVGMAPSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002212 purine nucleoside Substances 0.000 description 2
- 239000002718 pyrimidine nucleoside Substances 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 229940035893 uracil Drugs 0.000 description 2
- ODDDVFDZBGTKDX-VPCXQMTMSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-methyloxolan-2-yl]pyrimidine-2,4-dione Chemical compound C1=CC(=O)NC(=O)N1[C@]1(C)O[C@H](CO)[C@@H](O)[C@H]1O ODDDVFDZBGTKDX-VPCXQMTMSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- JBMBVWROWJGFMG-UHFFFAOYSA-N 2-chloro-7h-purine Chemical compound ClC1=NC=C2NC=NC2=N1 JBMBVWROWJGFMG-UHFFFAOYSA-N 0.000 description 1
- LMNPKIOZMGYQIU-UHFFFAOYSA-N 5-(trifluoromethyl)-1h-pyrimidine-2,4-dione Chemical compound FC(F)(F)C1=CNC(=O)NC1=O LMNPKIOZMGYQIU-UHFFFAOYSA-N 0.000 description 1
- LQLQRFGHAALLLE-UHFFFAOYSA-N 5-bromouracil Chemical compound BrC1=CNC(=O)NC1=O LQLQRFGHAALLLE-UHFFFAOYSA-N 0.000 description 1
- ZFTBZKVVGZNMJR-UHFFFAOYSA-N 5-chlorouracil Chemical compound ClC1=CNC(=O)NC1=O ZFTBZKVVGZNMJR-UHFFFAOYSA-N 0.000 description 1
- RHIULBJJKFDJPR-UHFFFAOYSA-N 5-ethyl-1h-pyrimidine-2,4-dione Chemical compound CCC1=CNC(=O)NC1=O RHIULBJJKFDJPR-UHFFFAOYSA-N 0.000 description 1
- KSNXJLQDQOIRIP-UHFFFAOYSA-N 5-iodouracil Chemical compound IC1=CNC(=O)NC1=O KSNXJLQDQOIRIP-UHFFFAOYSA-N 0.000 description 1
- ZKBQDFAWXLTYKS-UHFFFAOYSA-N 6-Chloro-1H-purine Chemical compound ClC1=NC=NC2=C1NC=N2 ZKBQDFAWXLTYKS-UHFFFAOYSA-N 0.000 description 1
- RYYIULNRIVUMTQ-UHFFFAOYSA-N 6-chloroguanine Chemical compound NC1=NC(Cl)=C2N=CNC2=N1 RYYIULNRIVUMTQ-UHFFFAOYSA-N 0.000 description 1
- OQRXBXNATIHDQO-UHFFFAOYSA-N 6-chloropyridine-3,4-diamine Chemical compound NC1=CN=C(Cl)C=C1N OQRXBXNATIHDQO-UHFFFAOYSA-N 0.000 description 1
- UIJIQXGRFSPYQW-UHFFFAOYSA-N 6-methylthiopurine Chemical compound CSC1=NC=NC2=C1N=CN2 UIJIQXGRFSPYQW-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 102100036286 Purine nucleoside phosphorylase Human genes 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 230000009615 deamination Effects 0.000 description 1
- 238000006481 deamination reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- AIHDCSAXVMAMJH-GFBKWZILSA-N levan Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(CO[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 AIHDCSAXVMAMJH-GFBKWZILSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001428 mercaptopurine Drugs 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- MRWXACSTFXYYMV-FDDDBJFASA-N nebularine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC=C2N=C1 MRWXACSTFXYYMV-FDDDBJFASA-N 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 108010009099 nucleoside phosphorylase Proteins 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229960004838 phosphoric acid Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- ZXYAAVBXHKCJJB-UHFFFAOYSA-N uracil-5-carboxylic acid Chemical compound OC(=O)C1=CNC(=O)NC1=O ZXYAAVBXHKCJJB-UHFFFAOYSA-N 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
この発明は、収率の高いヌクレオシド化合物の製造方法
に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] This invention relates to a method for producing nucleoside compounds with high yield.
塩基の交換反応を用いてヌクレオシド化合物を製造する
方法としては、N、Horl、 M、Watanabe
、 Y、Yaaazakl and Y、Mikaa+
1. Agrlc、Blol、Chem、、 53゜1
97 (1989)に報告された方法がある。この方法
は、プリンヌクレオシドホスホリラーゼとピリミジンヌ
クレオシドホスホリラーゼとを用い、リン酸の存在下に
おいて、チミンとイノシンとを反応させて塩基の交換反
応を行ない、リボース−1−リン酸を中間体として5−
メチルウリジンを製造するものである。A method for producing a nucleoside compound using a base exchange reaction is described by N., Horl, M., Watanabe.
, Y, Yaaazakl and Y, Mikaa+
1. Agrlc, Blol, Chem,, 53゜1
97 (1989). This method uses purine nucleoside phosphorylase and pyrimidine nucleoside phosphorylase, and in the presence of phosphoric acid, thymine and inosine are reacted to perform a base exchange reaction, using ribose-1-phosphate as an intermediate.
It produces methyluridine.
上記反応は、以下の二つの反応よりなる。The above reaction consists of the following two reactions.
−〉
イノシン+リン酸 〈−
リボース−1−リン酸中ヒポキサンチン (1)リボー
ス−1−リン酸+チミン;==寸5−メチルウリジン士
リン酸 (2)したがって、反応全体としては
、
イノシン+チミ7←−一−
5−メチルウラシル+ヒポキサンチン (3)である
。-> Inosine + phosphoric acid <- Hypoxanthine in ribose-1-phosphate (1) Ribose-1-phosphate + thymine; = = 5-methyluridine phosphoric acid (2) Therefore, the overall reaction is +Chimi7←-1-5-methyluracil+hypoxanthine (3).
前述の塩基の交換反応(3)の平衡定数Kl(Kl−[
5−メチルウリジン] [ヒポキサンチン]/[イノ
シン] [チミン])は0.21 (40℃)であり
、イノシシとチミンの初期濃度が同じであれば、収率は
平衡定数に規定されるので、5−メチルウリジンの最大
収率はわずか31%となる。これは、チミン以外の他の
塩基を用いた場合も同様であり、塩基の交換反応による
ヌクレオシド化合物の収率は低い値に止まっている。The equilibrium constant Kl (Kl-[
5-methyluridine] [hypoxanthine]/[inosine] [thymine]) is 0.21 (at 40°C), and if the initial concentrations of boar and thymine are the same, the yield is determined by the equilibrium constant. , the maximum yield of 5-methyluridine amounts to only 31%. This is the same when other bases than thymine are used, and the yield of nucleoside compounds due to base exchange reaction remains at a low value.
この発明は、塩基の交換反応を利用する、収率の高いヌ
クレオシド化合物の製造方法を提供することを目的とす
る。An object of the present invention is to provide a method for producing a nucleoside compound in high yield using a base exchange reaction.
本発明者らは、上記事情に鑑み、ヌクレオシド化合物の
収率をより高めるために鋭意研究を行なった。その結果
、塩基交換により生成されるヒポキサンチンを系から除
外することによりヌクレオシド化合物をより高収率で得
る方法を見出した。In view of the above circumstances, the present inventors conducted extensive research in order to further increase the yield of nucleoside compounds. As a result, we discovered a method for obtaining nucleoside compounds in higher yields by excluding hypoxanthine produced by base exchange from the system.
すなわち、この発明のヌクレオシド化合物の製造方法は
、イノシンおよびデオキシイノシンからなる群より選ば
れるヌクレオシドと、ピリミジン塩基およびプリン塩基
からなる群より選ばれる塩基とを、リン酸もしくはリン
酸塩存在下の水溶液中において、前記塩基がピリミジン
塩基の場合にはプリンヌクレオシドホスホリラーゼおよ
びピリーゼにより塩基交換反応させ、さらに、この塩基
交換反応により生成したヒポキサンチンをキサンチンオ
キシダーゼにより尿酸に変換させることを特徴とする。That is, the method for producing a nucleoside compound of the present invention comprises adding a nucleoside selected from the group consisting of inosine and deoxyinosine and a base selected from the group consisting of pyrimidine bases and purine bases to an aqueous solution in the presence of phosphoric acid or a phosphate salt. Among these, when the base is a pyrimidine base, a base exchange reaction is carried out using purine nucleoside phosphorylase and pyrease, and furthermore, hypoxanthine produced by this base exchange reaction is converted into uric acid by xanthine oxidase.
ここで、前記ピリミジン塩基としてはウラシル、シトシ
ン、チミン、5−フルオロウラシル、5−クロロウラシ
ル、5−ブロモウラシル、5−ヨードウラシル、5−エ
チルウラシル、5−トリフルオロメチルウラシル、5−
カルボキシウラシル等を、前記プリン塩基としてはアデ
ニン、グアニン、2−クロロプリン、6−クロロプリン
、2.6−ジクロロプリン、2−アミノ−6−クロロプ
リン、2.6−ジアミツプリン、6−メルカプトプリン
、6−メチルチオプリン、2−7ミノプリン等をそれぞ
れ挙げることができる。Here, the pyrimidine bases include uracil, cytosine, thymine, 5-fluorouracil, 5-chlorouracil, 5-bromouracil, 5-iodouracil, 5-ethyluracil, 5-trifluoromethyluracil, 5-
Carboxyuracil, etc., and the purine bases include adenine, guanine, 2-chloropurine, 6-chloropurine, 2.6-dichloropurine, 2-amino-6-chloropurine, 2.6-diamitpurine, 6-mercaptopurine. , 6-methylthiopurine, 2-7 minoprine, and the like.
以下、この発明のヌクレオシド化合物の製造方法を、ヌ
クレオシドと塩基交換反応を行なう塩基をピリミジン塩
基として詳細に説明する。Hereinafter, the method for producing a nucleoside compound of the present invention will be explained in detail using a pyrimidine base as a base that performs a base exchange reaction with a nucleoside.
まず、プリンヌクレオシドホスホリラーゼにより、出発
物質であるイノシンまたはデオキシイノシンとリン酸も
しくはリン酸塩とから、ヒポキサンチンとリボース−1
−リン酸もしくはデオキシリボース−1−リン酸が生成
する。First, purine nucleoside phosphorylase converts the starting materials inosine or deoxyinosine and phosphoric acid or phosphate into hypoxanthine and ribose-1.
- Phosphoric acid or deoxyribose-1-phosphate is produced.
次に、生成したリボース−1−リン酸もしくはデオキシ
リボース−1−リン酸が、ピリミジンヌクレオシドホス
ホリラーゼにより、ピリミジン塩基と置換反応を行なう
。これにより、リボース−1−リン酸とピリミジン塩基
との反応からピリミジンヌクレオシドが生成し、デオキ
シリボース−1−リン酸とじリミジン塩基との反応から
はピリミジンデオキシヌクレオシドが生成する。Next, the generated ribose-1-phosphate or deoxyribose-1-phosphate undergoes a substitution reaction with a pyrimidine base by pyrimidine nucleoside phosphorylase. As a result, pyrimidine nucleosides are produced from the reaction between ribose-1-phosphate and the pyrimidine base, and pyrimidine deoxynucleosides are produced from the reaction between deoxyribose-1-phosphate and the rimidine base.
これと同時に、反応溶液中に存在するピリミジンヌクレ
オシドホスホリラーゼにより、逆反応として、塩基交換
反応により生成したこれらのヌクレオシドおよびリン酸
もしくはリン酸塩が、再びピリミジン塩基とリボース−
1−リン酸もしくはデオキシリボース−1−リン酸とに
分解し、系全体として平衡状態に至る。At the same time, pyrimidine nucleoside phosphorylase present in the reaction solution causes a reverse reaction in which these nucleosides and phosphoric acid or phosphate produced by the base exchange reaction are again converted into pyrimidine bases and ribose-
It decomposes into 1-phosphoric acid or deoxyribose-1-phosphate, and the system as a whole reaches an equilibrium state.
しかしながら、この発明の方法においては、さらに、反
応溶液中にキサンチンオキシダーゼが共存している。こ
れにより、上記イノシンまたはデオキシイノシンの分解
により生成したヒポキサンチンは、酸素とキサンチンオ
キシダーゼにより不可逆的に酸化されてキサンチンを経
て尿酸となる。However, in the method of the present invention, xanthine oxidase is further present in the reaction solution. As a result, hypoxanthine produced by the decomposition of inosine or deoxyinosine is irreversibly oxidized by oxygen and xanthine oxidase to become uric acid via xanthine.
生成した尿酸は、プリンヌクレオシドホスホリラーゼお
よびピリミジンヌクレオシドホスホリラーゼの基質では
ないので、塩基の交換反応には関与せず、系から除外さ
れる。よって、化学量論的にイノシンは全てリボース−
1−リン酸と尿酸とになり、デオキシイノシンは全てデ
オキシリボース−1−リン酸と尿酸とになる。したがっ
て、イノシンまたはデオキシイノシンと塩基との初期濃
度が等しいときには、結果的にリボース−1−リン酸ま
たはデオキシリボース−1−リン酸と塩基との濃度は等
しい。よって、生成するヌクレオシドの生成量は、下式
の平衡定数にのみ依存する。Since the generated uric acid is not a substrate for purine nucleoside phosphorylase and pyrimidine nucleoside phosphorylase, it does not participate in the base exchange reaction and is excluded from the system. Therefore, stoichiometrically all inosine is ribose-
It becomes 1-phosphate and uric acid, and all deoxyinosine becomes deoxyribose-1-phosphate and uric acid. Therefore, when the initial concentrations of inosine or deoxyinosine and the base are equal, the resulting concentrations of ribose-1-phosphate or deoxyribose-1-phosphate and the base are equal. Therefore, the amount of nucleoside produced depends only on the equilibrium constant of the following formula.
リボース−1−リン酸
または 生塩基
デオキシリボース−1−リン酸
ヌクレオシド
−〉
〈−または +リン酸
デオキシヌクレオシド
ここで、出発物質としてイノシン、塩基としてチミンを
用いた場合を考えると、最終生成物である5−メチルウ
リジンは、上記式(2)に従って生成するので、その収
量は反応式(2)の平衡定数(K−[リボース−1−リ
ン酸コ [チミン]/[5−メチルウリジンコ [リン
酸] ) 0.082によって規定される。すなわち
、イノシンとリン酸の初期濃度を各々lおよびPとし、
イノシンとチミンの初期濃度を等しいとするとき、反応
終了時のチミンおよび5−メチルウリジンの濃度Tおよ
びMは以下の式(4)および(5)によって計算するこ
とができる。Ribose-1-phosphate or the raw base deoxyribose-1-phosphate nucleoside-〉〈- or + Phosphate deoxynucleoside Here, considering the case where inosine is used as the starting material and thymine as the base, the final product is Since a certain 5-methyluridine is produced according to the above formula (2), its yield is determined by the equilibrium constant (K-[ribose-1-phosphate co[thymine]/[5-methyluridine co[ Phosphoric acid] ) 0.082. That is, let the initial concentrations of inosine and phosphoric acid be l and P, respectively,
When the initial concentrations of inosine and thymine are equal, the concentrations T and M of thymine and 5-methyluridine at the end of the reaction can be calculated by the following equations (4) and (5).
15.12 T2 + (1+P) T−P−1−0(
4)M −1−T (5
)ヌクレオシドと交換反応を行なう塩基がプリン塩基で
ある場合には、イノシンまたはデオキシイノシンから生
じたリボース−1−リン酸またはデオキシリボース−1
−リン酸とプリン塩基との置換反応は、プリンヌクレオ
シドホスホリラーゼによって起こる。これにより、リボ
ース−1−リン酸とプリン塩基との反応からプリンヌク
レオシドか生成し、デオキシリボース−1−リン酸とプ
リン塩基との反応からはプリンデオキシヌクレオシドが
生成する。また、この逆反応である、プリンヌクレオシ
ドまたはプリンデオキシヌクレオシドとリン酸またはリ
ン酸塩とからプリン塩基とリボース−1−リン酸または
デオキシリボース−1−リン酸が生じる反応もプリンヌ
クレオシドホスホリラーゼによって起こる。したがって
、ヌクレオシドと交換反応を行なう塩基がプリン塩基で
ある場合には、ピリミジンヌクレオシドホスホリラーゼ
は必要ない。15.12 T2 + (1+P) T-P-1-0(
4) M -1-T (5
) When the base that performs the exchange reaction with the nucleoside is a purine base, ribose-1-phosphate or deoxyribose-1 generated from inosine or deoxyinosine
- The substitution reaction between phosphate and purine bases occurs by purine nucleoside phosphorylase. As a result, purine nucleosides are generated from the reaction between ribose-1-phosphate and purine bases, and purine deoxynucleosides are generated from the reaction between deoxyribose-1-phosphate and purine bases. Further, the reverse reaction of this reaction, in which purine base and ribose-1-phosphate or deoxyribose-1-phosphate are produced from purine nucleoside or purine deoxynucleoside and phosphoric acid or phosphate, also occurs by purine nucleoside phosphorylase. Therefore, when the base that undergoes the exchange reaction with the nucleoside is a purine base, pyrimidine nucleoside phosphorylase is not required.
本発明に用いられるキサンチンオキシダーゼ、プリンヌ
クレオ”シトホスホリラーゼ、およびピリミジンヌクレ
オシドホスホリラーゼは、いかなる起源のものでも構わ
ない。この発明において用いたキサンチンオキシダーゼ
は、ベーリンガー・マンハイム山之内社製の牛乳由来の
ものである。The xanthine oxidase, purine nucleo"cytophosphorylase, and pyrimidine nucleoside phosphorylase used in the present invention may be of any origin. The xanthine oxidase used in the present invention is derived from milk manufactured by Boehringer Mannheim Yamanouchi. .
また、この発明において用いたプリンヌクレオシドホス
ホリラーゼ、およびピリミジンヌクレオシドホスホリラ
ーゼは、この2種の酵素を同時に産生ずるバチラス・ス
テアロサーモスフイルスJTS859より調製した。Purine nucleoside phosphorylase and pyrimidine nucleoside phosphorylase used in this invention were prepared from Bacillus stearothermosophilus JTS859, which simultaneously produces these two enzymes.
この菌株は、通商産業省工業技術院微生物工業研究所に
寄託されており、その寄託番号は、微工研菌第9666
号(FERM P−9666)である。This strain has been deposited with the Institute of Microbiology, Agency of Industrial Science and Technology, Ministry of International Trade and Industry, and its deposit number is 9666.
No. (FERM P-9666).
この菌株の菌学的性質を、パージエイズ・マニュアル第
2巻に準じて検討した結果を以下に示す。The mycological properties of this strain were investigated in accordance with Purge Aids Manual Volume 2, and the results are shown below.
1、形態
桿菌:5.4〜B、5 、cnX Q、7〜0.9p
楕円形の胞子形成:2.0〜2.3ρ×1.1X1.2
gm。1, Bacillus morphology: 5.4-B, 5, cnX Q, 7-0.9p
Oval sporulation: 2.0~2.3ρ×1.1X1.2
gm.
1細胞に1個、位置は末端
2、培養的性質
NB培地 =62℃、2日間培養
平板上 :白色、僅かに黄色を含む
光沢あり
不透明
盛り上がらない
コロニーの形は円形波状
スラント上:白色、僅かに黄色を含む
光沢あり
不透明
盛り上からない
生育は中程度
3、生化学的性質
(1)ダラム染色 陽性(2)嫌気的培
養 生育せず(3)運動性
あり、周毛(4)オキシダーゼ
陽性(5)カタラーゼ 陽性(6)ゼラ
チンの液化 液化能あり(7)リドマスミル
ク 凝固させる(8)OFテスト
発酵タイプ(9)V−Pテスト
陰性(10)グルコースからの
ガスの発生 発生せず
(11)グルコースからの
酸の産生 産生じた
(12)アラビノースからの
酸の産生 産生ぜず
(13)マンニトールからの
酸の産生 産生した
(14)キジロールからの
酸の産生 産生ぜず
(15)サブロー培地での生育
スラント 生育した
液体 生育した
(1B) 0.001%リゾチーム下
での生育 生育せず
(17) 0.02%アザイド下
での生育 生育せず
(1g) 7%NaCI下での生育 生育せず(
2%までは生育した)
(I9)カゼインの加水分解 分解能あり(20
)デンプンの加水分解 分解能あり(21)ジヒ
ドロキシアセトンの
生成 生成せず
(22)エラグヨーク試験 生育せず(23)
クエン酸の利用 陰性(24)インドールの
産生 陰性(25)ウレアーゼ活性
陽性(26)フェニルアラニンの
脱アミノ化 陰性
(27)アルギニンデヒドロラーゼ
活性 陽性
(28)チロシンの分解 陰性(29)レバ
ンの産生 陰性(30)硝酸塩の還元
陽性(31)硝酸ナトリウムの
脱窒能 陰性
(32)硫化水素の生成 陽性(33)無機
窒素源の利用
NO,を唯一の
窒素源として 生育した
NH4を唯一の
窒素源として 生育した
(34)GC含量 47.3%(35
)生育温度 40〜71”Cで生育最適 6
0〜68℃
(3B) pH範囲 pH5,7〜8.
5最適pH6,0〜7.0
この発明の方法において、反応液は、イノシンまたはデ
オキシイノシン、アデニン、ウラシルおよびチミンから
なる群より選ばれる塩基、リン酸もしくはリン酸カリウ
ム等のリン酸塩、プリンヌクレオシドホスホリラーゼ、
ピリミジンヌクレオシドホスホリラーゼ、およびキサン
チンオキシダーゼを含めばよい。この反応液における、
イノシンまたはデオキシイノシシの濃度は5〜too
sM、塩基の濃度は5〜100 mM、およびリン酸も
しくはリン酸塩の濃度は5〜20 sMであることが好
ましい。イノシンまたはデすキシイノシンと塩基とは同
一濃度とし、イノシンまたはデオキシイノシシとリン酸
もしくはリン酸塩との濃度比は大きいほうがヌクレオシ
ド化合物の収率は増加する。反応液のpHは、7.0〜
9.0、好ましくは7.0〜8.0である。反応温度は
35℃ないし42℃、好ましくは37℃ないし40℃で
ある。1 per cell, located at terminal 2, culture properties NB medium = 62°C, 2 days culture on plate: white, slightly yellow, glossy, opaque, not raised Colony shape: circular wavy slant: white, slightly Glossy with yellow color, opaque, non-heavy growth, moderate growth (3), biochemical properties (1) Durham stain positive (2) anaerobic culture, no growth (3) motility
Yes, pericilla (4) oxidase
Positive (5) Catalase Positive (6) Liquefaction of gelatin Possible to liquefy (7) Lidomus milk coagulate (8) OF test
Fermentation type (9) V-P test
Negative (10) Production of gas from glucose Not produced (11) Production of acid from glucose Produced (12) Production of acid from arabinose No production (13) Production of acid from mannitol Produced (14) ) Acid production from Kijirole Production (15) Growth in Sabouraud medium Slant Growth Liquid Growth (1B) Growth under 0.001% lysozyme No growth (17) Under 0.02% azide Growth No growth (1g) Growth under 7% NaCI No growth (
(Grows up to 2%) (I9) Hydrolysis of casein Degradation ability (20
) Hydrolysis of starch Decomposition ability (21) Production of dihydroxyacetone Not produced (22) Elaguyoke test No growth (23)
Utilization of citric acid Negative (24) Production of indole Negative (25) Urease activity
Positive (26) Deamination of phenylalanine Negative (27) Arginine dehydrolase activity Positive (28) Degradation of tyrosine Negative (29) Production of levan Negative (30) Reduction of nitrate
Positive (31) Denitrifying ability of sodium nitrate Negative (32) Production of hydrogen sulfide Positive (33) Use of inorganic nitrogen source Grown with NO as the sole nitrogen source Grown with NH4 as the sole nitrogen source (34) GC Content 47.3% (35
) Growth temperature: Optimum growth at 40-71”C 6
0~68℃ (3B) pH range pH5,7~8.
5 Optimum pH 6.0 to 7.0 In the method of the present invention, the reaction solution contains a base selected from the group consisting of inosine or deoxyinosine, adenine, uracil and thymine, a phosphate such as phosphoric acid or potassium phosphate, and a purine. nucleoside phosphorylase,
Pyrimidine nucleoside phosphorylase and xanthine oxidase may be included. In this reaction solution,
The concentration of inosine or deoxyboar is 5-too
sM, the concentration of base is preferably 5-100 mM, and the concentration of phosphoric acid or phosphate is 5-20 sM. The concentration of inosine or deoxyinosine and the base is the same, and the higher the concentration ratio of inosine or deoxyinosine and phosphoric acid or phosphate, the higher the yield of the nucleoside compound. The pH of the reaction solution is 7.0~
9.0, preferably 7.0 to 8.0. The reaction temperature is 35°C to 42°C, preferably 37°C to 40°C.
反応液からの生成物の採取は、オクタデシル基の逆層ク
ロマトグラフィーにより好適に行なうことができる。The product can be suitably collected from the reaction solution by reverse layer chromatography using octadecyl groups.
製造例1 プリンヌクレオシドホスホリラーゼおよびピ
リミジンヌクレオシドホスホリラーゼの粗酵素液の調製
まず、バチルス・ステアロサーモフィルスJTS859
を、以下の手順で培養した。Production Example 1 Preparation of crude enzyme solutions of purine nucleoside phosphorylase and pyrimidine nucleoside phosphorylase First, Bacillus stearothermophilus JTS859
was cultured according to the following procedure.
菌の培養には、ペプトン20g1イーストエキス10
g、グルコース3gおよび水1gよりなるpH8,0の
培地を用いた。この培地2gに、バチルス・ステアロサ
ーモフィルスJTS859の胞子3.2X107個を添
加し、撹拌翼(直径80+am、上下部各6枚)を有す
るジャーファーメンタ−を用い、撹拌翼を88Orpm
で回転させつつ、通気量1.5 VV1%培養温度65
℃、pH5,9〜6.2で8時間培養した。For culturing bacteria, 20g peptone 10g yeast extract
A pH 8.0 medium consisting of 3 g, 3 g of glucose, and 1 g of water was used. Add 3.2 x 107 spores of Bacillus stearothermophilus JTS859 to 2 g of this medium, and use a Jarfer Mentor with stirring blades (diameter 80+ am, 6 upper and lower blades each) to adjust the stirring blades to 88 rpm.
While rotating at a ventilation rate of 1.5 VV1% culture temperature of 65
The cells were cultured for 8 hours at a temperature of 5.9 to 6.2.
培養終了後、菌体を遠心分離(10000g、4℃、1
5分)により集菌した。次いで、粗酵素液を以下のよう
にして調製した。After culturing, the bacterial cells were centrifuged (10,000 g, 4°C, 1
5 minutes) to collect bacteria. Next, a crude enzyme solution was prepared as follows.
得られた湿菌160gを500膓Mリン酸カリウム溶液
(pH7,0、以下単に「緩衝液」と記述する)に懸濁
し、ダイモミルで菌体を破壊した。次いで、緩衝液を添
加して全体を1400altとした後、遠心分離(83
00g、 20分)を行ない、上清1300−を得た。160 g of the obtained wet bacteria were suspended in a 500 M potassium phosphate solution (pH 7.0, hereinafter simply referred to as "buffer"), and the bacterial cells were disrupted with Dymomill. Next, a buffer solution was added to bring the whole to 1400 alt, and then centrifugation (83
00g for 20 minutes) to obtain a supernatant of 1300g.
沈殿物はさらに500@Iの緩衝液に懸濁して全体を1
030−とした後、遠心分離(8300g、 20分)
を行ない、上清990−を得た。この上清900−を先
の上清1300−と合わせ、63℃で1時間穏やかに撹
拌した。次いで、遠心分離(8300,g 、 40分
)を行ない、上清2130−を得た。The precipitate was further suspended in 500@I buffer and the whole was diluted to 1.
After adjusting to 030-, centrifugation (8300g, 20 minutes)
A supernatant 990- was obtained. This supernatant 900- was combined with the previous supernatant 1300- and gently stirred at 63° C. for 1 hour. Then, centrifugation (8300 g, 40 minutes) was performed to obtain supernatant 2130-.
この上清2130−を熱処理した後、−10℃に冷却し
たアセトン200−および緩衝液200allの混合溶
液を添加した。さらに、−10℃に冷却したアセトンI
、81を添加して5〜10℃で工5分間撹拌した後、遠
心分M (9000g、 5分)を行なった。得られ
た上清に一10℃のアセトン2.5gを添加して15分
間撹拌し、遠心分離(9000g、5分)を行なって沈
殿物を得た。この沈殿物を800−の緩衝液に懸濁させ
、アセトン処理済み粗酵素液850−を得た。After heat-treating this supernatant 2130-, a mixed solution of acetone 200- and 200 all buffer solutions cooled to -10°C was added. Furthermore, acetone I cooled to -10°C
. 2.5 g of acetone at -10° C. was added to the obtained supernatant, stirred for 15 minutes, and centrifuged (9000 g, 5 minutes) to obtain a precipitate. This precipitate was suspended in 800-buffer to obtain an acetone-treated crude enzyme solution 850-.
実施例1
5+nMのイノシン、5匝翼のチミン、5IIIMのリ
ン酸カリウム、キサンチンオキシダーゼIU 、および
粗酵素液(製造例1で得られたもの)25oρを含む1
−の反応液(pH7,0)を40℃で11時間反応させ
、反応液中に含まれる各成分の濃度を測定した。その結
果を第1図に示す。Example 1 1 containing 5+ nM inosine, 5 thymine, 5 IIIM potassium phosphate, IU xanthine oxidase, and 25 oρ of crude enzyme solution (obtained in Production Example 1)
- reaction solution (pH 7.0) was reacted at 40° C. for 11 hours, and the concentration of each component contained in the reaction solution was measured. The results are shown in FIG.
また、キサンチンオキシダーゼを添加しないこと以外は
全て上記手順と同一の条件で反応を行ない、反応後の各
成分の濃度を測定した。その結果を第2図に示す;
これらの図において、縦軸はmMで表わす各成分の濃度
、横軸は反応時間を示す。また、−0−はイノシン、−
・−はヒポキサンチン、−ローは5−メチルウリジン、
−■−はチミン、−ム−は尿酸、および−△−はキサン
チンをそれぞれ表わす。In addition, the reaction was carried out under the same conditions as the above procedure except that xanthine oxidase was not added, and the concentration of each component after the reaction was measured. The results are shown in FIG. 2; in these figures, the vertical axis shows the concentration of each component in mM, and the horizontal axis shows the reaction time. Also, -0- is inosine, -
・- is hypoxanthine, -rho is 5-methyluridine,
-■- represents thymine, -mu- represents uric acid, and -Δ- represents xanthine, respectively.
第1図および第2図より′明らかなように、キサンチン
オキシダーゼが存在する場合(第1図)には、存在しな
い場合(第2図)より、生成物である5−メチルウリジ
ンの含有量が非常に高くなっている。特に、キサンチン
オキシダーゼが存在する場合には、イノシン含有量の減
少に従ってヒポキサンチと共にキサンチンおよび尿酸が
見られるようになり、平衡状態では尿酸以外のイノシン
、ヒポキサンチンおよびキサンチンの含有量がほぼ0に
なることが示されている。これは、キサンチンオキシダ
ーゼにより、はぼ全てのイノシンが酸化されたことを示
している。As is clear from Figures 1 and 2, when xanthine oxidase is present (Figure 1), the content of the product 5-methyluridine is lower than when it is absent (Figure 2). It's very expensive. In particular, when xanthine oxidase is present, as the inosine content decreases, xanthine and uric acid are found together with hypoxanthine, and at equilibrium the content of inosine, hypoxanthine, and xanthine other than uric acid becomes almost 0. It is shown. This indicates that almost all inosine was oxidized by xanthine oxidase.
具体的には、キサンチンオキシダーゼが反応系に存在す
る場合には、3 、8mMの5−メチルウリジンが生成
した。存在しない場合には、5−メチルウリジンの生成
量は1.4EvMであった。Specifically, when xanthine oxidase was present in the reaction system, 3.8mM of 5-methyluridine was produced. In its absence, the amount of 5-methyluridine produced was 1.4 EvM.
このように、キサンチンオキシダーゼの存在下において
、より高い収率で5−メチルウリジンを得ることができ
た。Thus, in the presence of xanthine oxidase, 5-methyluridine could be obtained in higher yield.
実施例2
1〜20mMのチミン、チミンと同じ濃度のイノシン、
5ff1Mのリン酸カリウム、キサンチンオキシダーゼ
4U 、および粗酵素液(製造例1で得られたもの)
250dを含む反応液1−を40℃で反応さ七イノシ
ンが消失したときの5−メチルウリジンの存成量を測定
した。その結果を第3図に一争−でjす。この収量は、
破線で示す、式(4)、(5)で割算した理論曲線と比
べて大変よい一致をみた。Example 2 Thymine at 1-20mM, inosine at the same concentration as thymine,
5ff1M potassium phosphate, 4U of xanthine oxidase, and crude enzyme solution (obtained in Production Example 1)
Reaction solution 1- containing 250d was reacted at 40°C, and the amount of 5-methyluridine present when 7-inosine disappeared was measured. The results are shown in Figure 3. This yield is
A very good agreement was found compared with the theoretical curves calculated by dividing by equations (4) and (5), shown by the broken line.
実施例3および4
5mMのイノシン、下記第1表に示す5iMの塩層5d
のリン酸カリウム、キサンチンオキシダーゼ1υ、およ
び粗酵素液(製造例1で得られたもの250dを含むl
−の反応液(pH7,0)を40℃で8時間反応させ、
反応液中に含まれる生成ヌクレオシドの濃度を測定した
。Examples 3 and 4 5mM inosine, 5iM salt layer 5d as shown in Table 1 below
of potassium phosphate, xanthine oxidase 1υ, and crude enzyme solution (250d obtained in Production Example 1).
- reaction solution (pH 7,0) was reacted at 40°C for 8 hours,
The concentration of the produced nucleoside contained in the reaction solution was measured.
また、キサンチンオキシダーゼを添加しないこと以外は
全て上記手順と同一の条件で反応を行ない、反応後の生
成ヌクレオシドの濃度を測定したこれらの結果を、下記
第1表に併記した。In addition, the reaction was carried out under the same conditions as in the above procedure except that xanthine oxidase was not added, and the concentration of the produced nucleoside after the reaction was measured.The results are also shown in Table 1 below.
ヒ、 第1表
) 5″Mの2−デオキシイノシン・下記第2表に
示す51Xの塩基、5sMのリン酸カリウム、キサンチ
・ンオキシダーゼIU 、および粗酵素液(製造例1で
得られたもの) 250tlJを含む1wJの反応液
(pH7,0)を40℃で8時間反応させ、反応液中に
含まれる生成ヌクレオシドの濃度を測定した。(Table 1) 5''M 2-deoxyinosine, 51X base shown in Table 2 below, 5sM potassium phosphate, IU xanthine oxidase, and crude enzyme solution (obtained in Production Example 1) ) A 1 wJ reaction solution (pH 7.0) containing 250 tlJ was reacted at 40° C. for 8 hours, and the concentration of the produced nucleoside contained in the reaction solution was measured.
また、キサンチンオキシダーゼを添加しないこと以外は
全て上記手順と同一の条件で反応を行ない、反応後の生
成ヌクレオシドの濃度を測定した。In addition, the reaction was carried out under the same conditions as in the above procedure except that xanthine oxidase was not added, and the concentration of the produced nucleoside after the reaction was measured.
これらの結果を、下記第2表に併記した。These results are also listed in Table 2 below.
jfi2表
〔発明の効果〕
以上のように、この発明のヌクレオシド化合物の製造方
法は、塩基交換反応を利用して、簡便に、かつ高収率で
ヌクレオシド化合物を得ることが可能である。Table jfi2 [Effects of the Invention] As described above, the method for producing a nucleoside compound of the present invention makes it possible to easily obtain a nucleoside compound in high yield by utilizing a base exchange reaction.
第1図はこの発明の実施例1における反応液中の各成分
の濃度の経時変化を示すグラフ、第2図はキサンチンオ
キシダーゼを添加しないこと以外は第1図に示すグラフ
と同じ条件における反応液中の各成分の濃度の経時変化
を示すグラフ、および第3図は実施例2におけるチミン
濃度と5−メチルウリジン生成量との関係を示すグラフ
である。
第1図
第2図FIG. 1 is a graph showing changes over time in the concentration of each component in the reaction solution in Example 1 of the present invention, and FIG. 2 is a reaction solution under the same conditions as the graph shown in FIG. 1 except that xanthine oxidase was not added. FIG. 3 is a graph showing the relationship between the thymine concentration and the amount of 5-methyluridine produced in Example 2. Figure 1 Figure 2
Claims (2)
選ばれるヌクレオシドとピリミジン塩基とを、リン酸も
しくはリン酸塩存在下の水溶液中において、プリンヌク
レオシドホスホリラーゼおよびピリミジンヌクレオシド
ホスホリラーゼにより塩基交換反応させ、さらに、この
塩基交換反応により生成したヒポキサンチンをキサンチ
ンオキシダーゼにより尿酸に変換させることを特徴とす
るヌクレオシド化合物の製造方法。(1) A nucleoside selected from the group consisting of inosine and deoxyinosine and a pyrimidine base are subjected to a base exchange reaction with purine nucleoside phosphorylase and pyrimidine nucleoside phosphorylase in an aqueous solution in the presence of phosphoric acid or a phosphate salt, and then the base is A method for producing a nucleoside compound, which comprises converting hypoxanthine produced by an exchange reaction into uric acid using xanthine oxidase.
選ばれるヌクレオシドとプリン塩基とを、リン酸もしく
はリン酸塩存在下の水溶液中において、プリンヌクレオ
シドホスホリラーゼにより塩基交換反応させ、さらに、
この塩基交換反応により生成したヒポキサンチンをキサ
ンチンオキシダーゼにより尿酸に変換させることを特徴
とするヌクレオシド化合物の製造方法。(2) A nucleoside selected from the group consisting of inosine and deoxyinosine and a purine base are subjected to a base exchange reaction with purine nucleoside phosphorylase in an aqueous solution in the presence of phosphoric acid or a phosphate salt, and further,
A method for producing a nucleoside compound, which comprises converting hypoxanthine produced by this base exchange reaction into uric acid using xanthine oxidase.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP32233190A JP2572890B2 (en) | 1990-11-28 | 1990-11-28 | Method for producing nucleoside compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP32233190A JP2572890B2 (en) | 1990-11-28 | 1990-11-28 | Method for producing nucleoside compound |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04197193A true JPH04197193A (en) | 1992-07-16 |
JP2572890B2 JP2572890B2 (en) | 1997-01-16 |
Family
ID=18142453
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP32233190A Expired - Fee Related JP2572890B2 (en) | 1990-11-28 | 1990-11-28 | Method for producing nucleoside compound |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2572890B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0896065A1 (en) * | 1997-08-04 | 1999-02-10 | Yuki Gosei Kogyo Co., Ltd. | Method of preparing purine nucleoside compound |
US6316228B1 (en) * | 1996-10-21 | 2001-11-13 | The University Of Iowa Research Foundation | Efficient synthesis of nucleosides |
JP2015160832A (en) * | 2014-02-27 | 2015-09-07 | 大陽日酸株式会社 | Production method of nucleoside compound |
JP2015159772A (en) * | 2014-02-27 | 2015-09-07 | 大陽日酸株式会社 | Production method and composition of nucleoside compound |
-
1990
- 1990-11-28 JP JP32233190A patent/JP2572890B2/en not_active Expired - Fee Related
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6316228B1 (en) * | 1996-10-21 | 2001-11-13 | The University Of Iowa Research Foundation | Efficient synthesis of nucleosides |
EP0896065A1 (en) * | 1997-08-04 | 1999-02-10 | Yuki Gosei Kogyo Co., Ltd. | Method of preparing purine nucleoside compound |
CN1114698C (en) * | 1997-08-04 | 2003-07-16 | 有机合成药品工业株式会社 | Method of preparing purine nucleoside compound |
JP2015160832A (en) * | 2014-02-27 | 2015-09-07 | 大陽日酸株式会社 | Production method of nucleoside compound |
JP2015159772A (en) * | 2014-02-27 | 2015-09-07 | 大陽日酸株式会社 | Production method and composition of nucleoside compound |
Also Published As
Publication number | Publication date |
---|---|
JP2572890B2 (en) | 1997-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Schiefer-Ullrich et al. | Comparative studies on physiology and taxonomy of obligately purinolytic clostridia | |
JP3864357B2 (en) | Method for producing purine nucleoside compound | |
JP2795748B2 (en) | Method for producing nucleoside | |
JPS62201577A (en) | Beta-amylase | |
JPH04197193A (en) | Production of nucleoside compound | |
Hori et al. | Synthesis of 5-methyluridine by a thermophile, Bacillus stearothermophilus JTS 859 | |
JPH05292945A (en) | New bacillus-subtilis | |
JP2534807B2 (en) | Method for producing nucleoside compound | |
JP3026857B2 (en) | Novel pullulanase and method for producing the same | |
Kusakabe et al. | Extracellular production of l-lysine α-oxidase in wheat bran culture of a strain of Trichoderma viride | |
EP0169920B1 (en) | Process for thermally stable alpha-amylase production | |
EP0179468B1 (en) | Production of uridine | |
JP4058663B2 (en) | Method for producing ribose 1-phosphates and nucleoside compounds | |
JP3731237B2 (en) | Method for producing nucleoside compound | |
JPS6111598B2 (en) | ||
JPH0515368A (en) | New pullulanase and production thereof | |
JP2001269192A (en) | Method for producing guanosines and its intermediates | |
EP0206595B1 (en) | Thermally stable tryptophanase process for producing the same, and thermally stable tryptophanase-producing microorganism | |
JP4058667B2 (en) | Method for producing 2'-deoxynucleoside compound | |
JPH01320995A (en) | Production of nucleoside compound | |
JP2768473B2 (en) | Method for producing NADH oxidase | |
JP2544480B2 (en) | Purine nucleoside phosphorylase and method for producing the same | |
JP2548356B2 (en) | Brin nucleoside phosphorylase and method for producing the same | |
JP2547438C (en) | ||
JPH099960A (en) | New pyruvic oxidase, its production and analysis of pyruvic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20071024 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081024 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091024 Year of fee payment: 13 |
|
LAPS | Cancellation because of no payment of annual fees |